DARWIN Biomed raises EUR1M pre-seed for MICHELANGELO walker
DARWIN Biomed closed a €1 million pre-seed round to accelerate development and clinical validation of its assistive-robotics technology.
Why it matters
The round funds clinical validation and international commercialization work for assistive healthcare robotics.
Evidence notes
- DARWIN Biomed closed a EUR1 million pre-seed round.
- The round was led by Easo Ventures and Sodena, with ERREKA named as an industrial partner for the MICHELANGELO smart walker.
- The event adds a concrete robotics milestone in human-assistive, manipulation or human-machine interaction workflows.
Company context
DARWIN Biomed develops MICHELANGELO, an assistive smart walker that combines sensors, motorized wheels and active fall-prevention logic for healthcare and mobility support.